Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Biohit Forms China JV for Diagnostic Test

publication date: Jun 25, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Biohit Oyj, a Finnish diagnostics company, and Anhui Wisdom-Win Investment Co. will establish a JV to make and sell Biohit’s GastroPanel kits to the China market. GastroPanel is a non-invasive test for low levels of acid in the stomach. The disorder can be caused by H. pylori infection or dysfunction of the stomach mucosa (atrophic gastritis). Wisdom-Win will invest 20 million RMB ($3.2 million) for 60% ownership of the JV, while Biohit Oyj’s technology, valued at 13 million RMB, will earn it a 40% stake. More details....

Stock Symbol: (HEL: BIOBV)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors